2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: Developed by the Task Force on cardiac pacing and cardiac resynchronization …
M Glikson, JC Nielsen, MB Kronborg, Y Michowitz… - EP …, 2022 - academic.oup.com
for digital applications (smartphones, etc.). These versions are abridged and thus, for more
detailed information, the user should always access to the full text version of the guidelines …
detailed information, the user should always access to the full text version of the guidelines …
Systemic delivery of bone marrow–derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution
IM Barbash, P Chouraqui, J Baron, MS Feinberg… - Circulation, 2003 - Am Heart Assoc
Background—Systemic delivery of bone marrow–derived mesenchymal stem cells (BM-
MSCs) is an attractive approach for myocardial repair. We aimed to test this strategy in a rat …
MSCs) is an attractive approach for myocardial repair. We aimed to test this strategy in a rat …
Meta-analysis of predictors of all-cause mortality after transcatheter aortic valve implantation
F Giordana, F D'Ascenzo, F Nijhoff, C Moretti… - The American journal of …, 2014 - Elsevier
The aim of this study was to identify predictors of 30-day and midterm mortality after
transcatheter aortic valve implantation (TAVI) by means of a systemic review. TAVI was …
transcatheter aortic valve implantation (TAVI) by means of a systemic review. TAVI was …
Bioengineered cardiac grafts: a new approach to repair the infarcted myocardium?
J Leor, S Aboulafia-Etzion, A Dar, L Shapiro… - Circulation, 2000 - Am Heart Assoc
Background—The myocardium is unable to regenerate because cardiomyocytes cannot
replicate after injury. The heart is therefore an attractive target for tissue engineering to …
replicate after injury. The heart is therefore an attractive target for tissue engineering to …
Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium
Y Amsalem, Y Mardor, MS Feinberg, N Landa, L Miller… - Circulation, 2007 - Am Heart Assoc
Background—Cell labeling with superparamagnetic iron oxide (SPIO) nanoparticles
enables noninvasive MRI and tracking of transplanted stem cells. We sought to determine …
enables noninvasive MRI and tracking of transplanted stem cells. We sought to determine …
The state of the excimer laser for coronary intervention in the drug-eluting stent era
OBJECTIVES: This study aims to determine how excimer laser coronary atherectomy
(ELCA) performs in the drug-eluting stent (DES) era. BACKGROUND: For more than …
(ELCA) performs in the drug-eluting stent (DES) era. BACKGROUND: For more than …
Influence of embryonic cardiomyocyte transplantation on the progression of heart failure in a rat model of extensive myocardial infarction
S Etzion, A Battler, IM Barbash, E Cagnano… - Journal of molecular and …, 2001 - Elsevier
S. Etzion, A. Battler, IM Barbash, E. Cagnano, P. Zarin, Y. Granot, LH Kedes, RA Kloner and
J. Leor. Influence of Embryonic Cardiomyocyte Transplantation on the Progression of Heart …
J. Leor. Influence of Embryonic Cardiomyocyte Transplantation on the Progression of Heart …
Ex vivo activated human macrophages improve healing, remodeling, and function of the infarcted heart
J Leor, L Rozen, A Zuloff-Shani, MS Feinberg… - Circulation, 2006 - Am Heart Assoc
Background—Activated macrophages have a significant role in wound healing and
damaged tissue repair. We sought to explore the ability of ex vivo activated macrophages to …
damaged tissue repair. We sought to explore the ability of ex vivo activated macrophages to …
Comparison of vascular closure devices for access site closure after transfemoral aortic valve implantation
IM Barbash, M Barbanti, J Webb… - European heart …, 2015 - academic.oup.com
Background The majority of transcatheter aortic valve implantation (TAVI) procedures are
currently performed by percutaneous transfemoral approach. The potential contribution of …
currently performed by percutaneous transfemoral approach. The potential contribution of …
Incidence and predictors of acute kidney injury after transcatheter aortic valve replacement
IM Barbash, I Ben-Dor, D Dvir, G Maluenda, Z Xue… - American heart …, 2012 - Elsevier
BACKGROUND: Patients undergoing transcatheter aortic valve replacement (TAVR) are at
increased risk for acute kidney injury (AKI). The Valve Academic Research Consortium …
increased risk for acute kidney injury (AKI). The Valve Academic Research Consortium …